Life Science Big News Roundup: Makers of Malboro Fund Lexaria’s Oral Nicotine Project; NanoSphere Signs Licensing Agreement with Delta 9 Cannabis Inc. Biotech Investing
Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application Life Science Investing News
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification Medical Device Investing
Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio Medical Device Investing
Eton Pharmaceuticals Announces Licensing of Oral Liquid Product Candidate ET-104 Life Science Investing News
